CVS Drops Sanofi ' s Diabetes Drugs for Biosimilars CVS Drops Sanofi ' s Diabetes Drugs for Biosimilars

U.S. pharmacy benefit manager CVS will drop Sanofi ' s main insulin drug Lantus from the list of medicines it reimburses on behalf of health insurers, dealing a blow to the French drugmaker ' s key diabetes business.Reuters Health Information
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news